Literature DB >> 2757120

The role of fibronectin in the development of experimental amyloidosis. Evidence of immunohistochemical codistribution and binding property with serum amyloid protein A.

E Kawahara1, M Shiroo, I Nakanishi, S Migita.   

Abstract

Azocasein-induced amyloid A (AA) amyloidosis in CBA/K1Jms mice was investigated to elucidate a preference of serum amyloid A (SAA) deposition in the spleen. By indirect immunofluorescence using anti-SAA/AA antibodies the initial deposition of SAA/AA was recognized in the marginal zone of spleen at 20 days after azocasein injection. Indirect immunofluorescence using anti-fibronectin antibodies also showed meshwork positivity in the corresponding area more intensely than that in controls. Immunoelectron microscopy using anti-SAA/AA revealed the presence of positively stained flocculent materials on cell surfaces of macrophages in the marginal area in addition to amyloid fibril. The tissue fibronectin rapidly increased in the spleen and maintained 10 times more than that of controls until the 20th day. Binding assay of SAA on frozen sections revealed the presence of SAA-binding substances in the perifollicular area. Affinity chromatographic assay showed fibronectin have a binding capacity to SAA1 and SAA2. By binding assay on the microtiter plate, SAA had more affinity to fibronectin than those of heparan sulfate, collagen type I, or serum amyloid P component. These results indicate that fibronectin plays an important role in the development of amyloidosis by working as a linking protein between SAA and the cell surface of macrophages.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2757120      PMCID: PMC1879956     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  38 in total

1.  Fibronectin is an acute phase reactant in mice.

Authors:  R F Dyck; S L Rogers
Journal:  Clin Invest Med       Date:  1985       Impact factor: 0.825

2.  Immunohistochemical demonstration of vitronectin in association with elastin and amyloid deposits in human kidney.

Authors:  K Dahlbäck; H Löfberg; B Dahlbäck
Journal:  Histochemistry       Date:  1987

3.  Presence and role of glycosaminoglycans in amyloidosis.

Authors:  A Linker; H C Carney
Journal:  Lab Invest       Date:  1987-09       Impact factor: 5.662

4.  Characterization of tissue and plasma glycosaminoglycans during experimental AA amyloidosis and acute inflammation. Qualitative and quantitative analysis.

Authors:  A D Snow; R Kisilevsky; C Stephens; T Anastassiades
Journal:  Lab Invest       Date:  1987-06       Impact factor: 5.662

5.  Human spleen contains phenotypic subsets of macrophages and dendritic cells that occupy discrete microanatomic locations.

Authors:  P J Buckley; M R Smith; M F Braverman; S A Dickson
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

6.  Alveolar hydatid cyst induced amyloid enhancing factor (AEF): physicochemical properties and abolition of AEF activity by serine protease inhibitors.

Authors:  G V Abankwa; Z Ali-Khan
Journal:  Br J Exp Pathol       Date:  1988-02

7.  Specific deposition of serum amyloid A protein 2 in the mouse.

Authors:  M Shiroo; E Kawahara; I Nakanishi; S Migita
Journal:  Scand J Immunol       Date:  1987-12       Impact factor: 3.487

8.  Desmoplastic reaction of gastric carcinoma: a light- and electron-microscopic immunohistochemical analysis using collagen type-specific antibodies.

Authors:  T Minamoto; A Ooi; Y Okada; M Mai; Y Nagai; I Nakanishi
Journal:  Hum Pathol       Date:  1988-07       Impact factor: 3.466

9.  Expression of glial fibrillary acidic protein (GFAP) in peripheral nerve sheath tumors. A comparative study of immunoreactivity of GFAP, vimentin, S-100 protein, and neurofilament in 38 schwannomas and 18 neurofibromas.

Authors:  E Kawahara; Y Oda; A Ooi; S Katsuda; I Nakanishi; S Umeda
Journal:  Am J Surg Pathol       Date:  1988-02       Impact factor: 6.394

10.  Interaction of small dermatan sulfate proteoglycan from fibroblasts with fibronectin.

Authors:  G Schmidt; H Robenek; B Harrach; J Glössl; V Nolte; H Hörmann; H Richter; H Kresse
Journal:  J Cell Biol       Date:  1987-06       Impact factor: 10.539

View more
  11 in total

1.  Microfilamentous type VI collagen in the hyalinized stroma of the hypertrophied ligamentum flavum.

Authors:  E Kawahara; Y Oda; S Katsuda; I Nakanishi; K Aoyama; K Tomita
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

2.  Left ventriculotomy of the heart: tissue repair and localization of collagen types I, II, III, IV, V, VI and fibronectin.

Authors:  E Kawahara; A Mukai; Y Oda; I Nakanishi; T Iwa
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

3.  Amyloid resistance in A/J mice is not determined by genetic variants at, or close to, the serum amyloid P component locus.

Authors:  A S Whitehead; W Gonnerman; D M Steel; K Zahedi
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

4.  Major acute-phase reactant synthesis during chronic inflammation in amyloid-susceptible and -resistant mouse strains.

Authors:  K Zahedi; W A Gonnerman; F C Debeer; M C Debeer; D M Steel; J D Sipe; A S Whitehead
Journal:  Inflammation       Date:  1991-02       Impact factor: 4.092

Review 5.  Amyloid in the cardiovascular system: a review.

Authors:  I Kholová; H W M Niessen
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

6.  High molecular weight glycosaminoglycans in AA type amyloid fibril extracts from human liver.

Authors:  J H Magnus; S O Kolset; G Husby
Journal:  Ann Rheum Dis       Date:  1991-08       Impact factor: 19.103

7.  Fibronectin and basement membrane components in renal amyloid deposits in patients with primary and secondary amyloidosis.

Authors:  G T Westermark; B Norling; P Westermark
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

8.  Characterization of proteoglycans associated with mouse splenic AA amyloidosis.

Authors:  T Stenstad; J H Magnus; G Husby
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

9.  Inhibitory effects of adhesion oligopeptides on the invasion of squamous carcinoma cells with special reference to implication of alpha v integrins.

Authors:  E Kawahara; K Imai; S Kumagai; E Yamamoto; I Nakanishi
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

10.  Linkage of protection against amyloid fibril formation in the mouse to a single, autosomal dominant gene.

Authors:  W A Gonnerman; R Elliott-Bryant; I Carreras; J D Sipe; E S Cathcart
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.